Based on the Adhera Therapeutics Inc stock forecast from 0 analysts, the average analyst target price for Adhera Therapeutics Inc is not available over the next 12 months. Adhera Therapeutics Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Adhera Therapeutics Inc is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Adhera Therapeutics Inc’s stock price was USD 0.00. Adhera Therapeutics Inc’s stock price has changed by -91.67% over the past week, -91.67% over the past month and -99.33% over the last year.
No recent analyst target price found for Adhera Therapeutics Inc
No recent average analyst rating found for Adhera Therapeutics Inc
Company Overview Adhera Therapeutics Inc
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Read Less
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known ...Read More
Frequently Asked Questions About Adhera Therapeutics Inc (ATRX) Stock
Stock Target Advisor's fundamental analysis for Adhera Therapeutics Inc's stock is Bearish.
Unfortunately we do not have enough data on ATRX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ATRX's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ATRX's stock to indicate if its overvalued.
The last closing price of ATRX's stock was USD 0.00.
The most recent market capitalization for ATRX is USD 1.44K.
Unfortunately we do not have enough analyst data on ATRX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Adhera Therapeutics Inc's stock.
As per our most recent records Adhera Therapeutics Inc has 2 Employees.
Adhera Therapeutics Inc's registered address is 8000 Innovation Parkway, Baton Rouge, LA, United States, 70820.
You can get more information about it from Adhera Therapeutics Inc's website at https://adherathera.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Adhera Therapeutics Inc (ATRX) Stock
Stock Target Advisor's fundamental analysis for Adhera Therapeutics Inc's stock is Bearish.
Unfortunately we do not have enough data on ATRX's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ATRX's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on ATRX's stock to indicate if its overvalued.
The last closing price of ATRX's stock was USD 0.00.
The most recent market capitalization for ATRX is USD 1.44K.
Unfortunately we do not have enough analyst data on ATRX's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Adhera Therapeutics Inc's stock.
As per our most recent records Adhera Therapeutics Inc has 2 Employees.
Adhera Therapeutics Inc's registered address is 8000 Innovation Parkway, Baton Rouge, LA, United States, 70820.
You can get more information about it from Adhera Therapeutics Inc's website at https://adherathera.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ATRX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
